Dr. Pat Soon-Shiong: Cytokine or Cytopathic Storm?

Video

Dr. Patrick Soon-Shiong, CEO of ImmunityBio, initiates a conversation on the nature of the SARS-CoV-2 cytokine storm.

Dr. Patrick Soon-Shiong, CEO of ImmunityBio, initiates a conversation on the nature of the SARS-CoV-2 cytokine storm.

Related Videos
Related Content

Federal Agencies Work to Make RSV Monoclonal Antibody Immunization Accessible to Families

November 18th 2023

Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

November 6th 2023

FDA Clears Way for Marketing First OTC COVID-19 Antigen Test

November 10th 2023

Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir

February 11th 2022

Testing for Viral Respiratory Illnesses: Best Practices, Types of Tests, Advantages and Drawbacks, and Patient/Provider Education

November 2nd 2023

Examining RSV Vaccines for Seniors

November 2nd 2023

Federal Agencies Work to Make RSV Monoclonal Antibody Immunization Accessible to Families

November 18th 2023

Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

November 6th 2023

FDA Clears Way for Marketing First OTC COVID-19 Antigen Test

November 10th 2023

Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir

February 11th 2022

Testing for Viral Respiratory Illnesses: Best Practices, Types of Tests, Advantages and Drawbacks, and Patient/Provider Education

November 2nd 2023

Examining RSV Vaccines for Seniors

November 2nd 2023

Federal Agencies Work to Make RSV Monoclonal Antibody Immunization Accessible to Families

November 18th 2023

Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

November 6th 2023

FDA Clears Way for Marketing First OTC COVID-19 Antigen Test

November 10th 2023

Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir

February 11th 2022

Testing for Viral Respiratory Illnesses: Best Practices, Types of Tests, Advantages and Drawbacks, and Patient/Provider Education

November 2nd 2023

Examining RSV Vaccines for Seniors

November 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.